Table 1 Literature that informed the identification of select bacteria explored in association with stress domains.

From: Biological, environmental, and psychological stress and the human gut microbiome in healthy adults

Select bacteria

Article

Study description

Findings specific to select bacteria

Lactobacillus

Aizawa et al., 2016

Cross-sectional human study (N = 100; n = 43) comparing fecal microbiome samples of patients with major depressive disorder (MDD) to healthy controls

Patients with MDD had lower Lactobacillus counts than healthy controls

Messaoudi et al., 2011

30-day clinical trial of healthy adults (N = 55; n = 26) who were administered probiotic formula Lactobacillus helveticus R0052 and Bifidobacterium longum R0175

Alleviated psychological distress in healthy adults compared to healthy controls

Kim et al., 2020

Escherichia coli and Lactobacillus mucosae were isolated from healthy human feces and administered to mice (n = 7)

Oral gavage of E.coli caused depression in mice. Treatment with L.mucosae reduced E.coli induced depression

Akkermansia

Delgadillo et al., 2022

Cross-sectional study of human toddlers (N = 77) using fecal microbiome samples

Akkermansia was associated with increased emotion regulation in children

Ding et al., 2021

Mice treated with Akkermansia muciniphila (AKK) for 3 weeks prior to chronic restraint stress (n = 6)

AKK treatment reduced depressive-like behaviors compared to untreated controls

Bifidobacterium

Aizawa et al., 2016

Cross-sectional human study (N = 100; n = 43) comparing fecal microbiome samples of patients with MDD to healthy controls

Patients with MDD had significantly lower Bifidobacterium counts compared to controls

Liu et al., 2016

Cross-sectional human study (N = 100) comparing microbial composition (fecal samples) in IBS subgroups (n = 65), healthy controls (n = 20) and those with depression (n = 15)

Those with depression had significantly lower levels of Bifidobacterium compared to controls

Streptococcus

Gao et al., 2018

Mice were exposed to chronic stress for one month (n = 4–5)

Relative to normal mice, stressed mice showed increased levels of inflammation promoting bacteria, including Streptococcus

Nishida et al., 2019

Japanese medical students (N = 60; n = 31) were randomly assigned to a placebo or probiotic treatment (1 tablet taken daily for 24 weeks) group prior to the national examination for medical practitioners. Fecal samples were collected pre and post treatment

Levels of Streptococcus were elevated in the placebo group compared to the control group

Escherichia/Shigella

Bashir et al., 2024

Cross-sectional study of healthy adult women (N = 160) measuring symptoms of stress, depression, fecal, and vaginal microbiome

The relative abundance of Escherichia and Shigella were elevated in women with greater depression symptoms

Chen et al., 2021

Cross-sectional study of adult female patients (N = 108; n = 62) comparing fecal microbiome samples of patients with MDD to healthy controls

Patients with MDD had higher levels of Escherichia/Shigella than healthy controls

Clostridium

Bailey et al., 2011

Mice (n = 5) were exposed to a 2-hour social defeat stressor for six days and cecal microbiota were assayed

Stressor exposure increased relative abundances of Clostridium

Mullie et al., 2002

Fecal microbiome samples were collected from healthy males (N = 10) six weeks prior to and during final examinations

A rise in Clostridium perfringens was observed during the examination period

  1. Note. Both total sample size (N) and treatment group sample size (n) are reported in human studies when applicable.